Pharmaceutical Litigation Lawyers in the USA

New Jersey federal and state courts and the U.S. Supreme Court, in addition to a federal court in New York, have issued a number of opinions regarding products liability and related issues since the beginning of 2011. Below is a synopsis of some of the more interesting and important of those decisions.

Pfizer has agreed to pay $14.5 million to settle a lawsuit alleging that it violated the False Claims Act by improperly marketing its prescription drugs Detrol and Detrol LA.

Transvaginal Mesh products have been associated with a number of complications. Lawsuits have been intiated in multiple courts. In 2011, the United States Food and Drug Administration (FDA), have issued a warning to inform patients and healthcare providers of serious complications associated with implantation of surgical mesh for transvaginal repair of Pelvic Organ Prolapse.

The diabetes drug Actos has been linked to Bladder Cancer. Litigation is now underway as a new study confirms the actos bladder cancer link. Pioglitazone (Actos) is an antidiabetic agent in the thiazolidinedione drug class. The British Medical Journal published an article May 31, 2012, stating that pioglitazone has been found to be associated with an increased risk of bladder cancer development according to a case-control study.

The diabetes drug Actos has been linked to Bladder Cancer. Litigation is now underway and Canada recently warned it's citizens of this risk. As more and more patients are reporting the development of bladder cancer, Canada adds themselves to the list of nations that are warning their citizens of the severe risks of using Actos for a long period of time.

The Infuse Bone Graft by Medtronic has been used off-label and been associated with major side effects. Can you imagine how it would feel to have to fight for every breath? How would you feel if swallowing became so difficult and there was no relief in sight? This is the fate of thousands of patients who suffer side-effects after surgical implantation of a Medtronic Infuse Bone Graft placed in the cervical spine.

Slimquick is marketed as a weight loss dietary supplement for women. The following are 5 key facts about Slimquick that the manufacturers don't want you to know about:

The Need for Stroke and Heart Attack Medication - According to the Centers for Disease Control and Prevention, stroke is the fourth leading cause of death in the U.S. Healthy blood vessels allow oxygen and other nutrients to flow to the brain. When a clot is formed that blocks the brain’s input of blood, a stroke may result, resulting in mild, moderate or severe impairment - or death.

Pradaxa is an anticoagulant, or blood thinner, that was approved by the FDA in Oct. 2011 to prevent blood clots in patients who experience atrial fibrillation, or irregular heartbeat. When the heart does not beat in a regular, healthy rhythm, blood may collect in the heart and clots may form as it collects. If a clot is pumped into the bloodstream and it reaches the brain, a stroke may result. Pradaxa was designed to thin the blood, allowing it to flow freely without clotting.

The Medtronic Infuse Bone Graft has been used off label in a number of procedures and has caused serious complications including cancer, neck swelling, airway compression, difficulty breathing, nerve damage, and other life threatening complications.